![](https://ml.globenewswire.com/media/3f5f8c7b-56c1-4baf-bb5f-3a016ab02d6f/small/briacell-logo-v4-1-final-jpg.jpg)
BriaCell Announces $350,000 Equity Investment by Board of Directors
BERKELEY, Calif. and VANCOUVER, British Columbia, July 23, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF), a clinical-stage biotechnology company specializing in targeted …